Investing in companies that provide essential products and services is a smart wealth-building strategy. Like it or not, health insurance ranks as one of the most important necessities for Americans today. However, in 2025, the U.S. health insurance sector faces significant pressures and risks. The Medical Cost Ratio (MCR) has been elevated this year; for instance, UnitedHealth Group’s MCR reached a historic high of 89.4% in Q2 2025.
Despite these risks, demand for health insurance remains relatively stable. Furthermore, an aging population is driving growth in demand for Medicare Advantage and Medicare supplemental plans. The Trump administration in its second term could particularly promote Medicare Advantage plans, creating new growth opportunities for the industry. Therefore, the current cost pressures are more akin to a short-term stress test of each company’s operational efficiency and cost control capabilities. For long-term investors, the sector’s short-term weakness may present an opportunity to acquire leading companies at lower prices.
The subsequent question is: how to select quality health insurance stocks? What key points should investors know before investing? Here is a comprehensive analysis.
Beyond universal metrics like revenue and earnings growth, three industry-specific factors demand attention:
(Data as of September 3, 2025)
| Name & Ticker | Market Cap | Dividend Yield | Industry |
| UnitedHealth Group (UNH) | $280B | 2.76% | Healthcare Providers & Services |
| Elevance Health (ELV) | $73B | 2.07% | Healthcare Providers & Services |
| CVS Health (CVS) | $94B | 3.59% | Healthcare Providers & Services |
| Centene (CNC) | $15B | 0.00% | Healthcare Providers & Services |
| iShares U.S. Healthcare Providers ETF (IHF) | – | 0.00% | Capital Markets |
As the world’s largest health insurer, its UnitedHealthcare unit offers health plans for employers and individuals and is a major player in Medicare Advantage, Medicare supplements, and Medicaid. Its Optum segment provides technology-enabled health services. While UnitedHealthcare generates about three-fourths of total revenue, Optum is the primary growth engine. Recent growth has been fueled by acquisitions, including Change Healthcare in 2022 and the $3.3 billion purchase of home health provider Amedisys in August 2025.
Beyond its pharmacy retail business, CVS runs CVS Caremark, one of the largest Pharmacy Benefit Managers (PBMs) in the U.S. Its acquisition of Aetna in 2018 made it a top health insurer. The healthcare benefits segment (mainly Aetna) contributes over one-third of total revenue and is growing rapidly, driven by Medicare and commercial insurance products. It offers the highest dividend yield in this group.
Centene focuses largely on the Medicaid market. Traditional participants (including those in CHIP and TANF programs) and individuals requiring frequent monitoring comprise over half of its total membership. Medicaid plans generate nearly two-thirds of its revenue. However, its Medicare and commercial insurance businesses are growing at a much faster rate. Future growth targets include dual eligibles (qualifying for both Medicare and Medicaid) and the Individual Coverage Health Reimbursement Arrangement (ICHRA).
Formerly known as Anthem, it operates Blue Cross and/or Blue Shield plans in 14 states but is licensed nationwide. Its offerings include employer-sponsored and individual health plans, Medicare Advantage, Medicare supplements, and Medicaid. Its diversified businesses include PBM CarelonRx and healthcare services platform Carelon Services. The health benefits segment contributes over 80% of revenue, but Carelon Services is its fastest-growing unit.
This ETF tracks the Dow Jones U.S. Select Healthcare Providers Index, which includes U.S. companies providing health insurance, diagnostics, and specialized treatment. Its four largest holdings are UnitedHealth, CVS Health, Elevance Health, and Humana. Two primary drawbacks compared to direct stock ownership are: its holdings extend beyond pure-play health insurers, and it carries an annual expense fee of 0.38%.
